Tatva Chintan Pharma’s ₹ 500 crore preliminary public providing (IPO) was subscribed 4.51 occasions on the primary day of its situation at this time, based on subscription knowledge on the exchanges. The IPO of the specialty chemical firm opened for traders on Friday, July 16, and can shut on July 20. The portion reserved for retail particular person traders was subscribed essentially the most at this time, whereas certified institutional consumers confirmed tepid curiosity. (Additionally Learn: Tatva Chintan Pharma IPO Opens Right now; Right here Are Issues To Know )
The portion reserved for retail traders within the IPO was subscribed 8.24 occasions by 5:00 pm at this time – the very best among the many three teams of traders. The portion put aside for the certified institutional consumers (QIB) was subscribed 0.50 occasions, whereas the portion reserved for non-institutional traders (NII) was subscribed 1.14 occasions.
The IPO consists of a recent situation of shares value ₹ 225 crore and a proposal of sale aggregating to ₹ 225 crore by the prevailing promoters and shareholders. The shares are provided within the worth band of ₹ 1,073-1,083 per share. Traders can apply for a minimal one lot of 13 shares and in multiples thereafter, extending as much as a most of 14 tons.